Definitive Deferred Long Term Liab from 2010 to 2024
| DH Stock | USD 4.45 0.08 1.83% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 17.5 M | Current Value 9.6 M | Quarterly Volatility 5.4 M |
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.6 M, Interest Expense of 16.7 M or Selling General Administrative of 35.5 M, as well as many indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.0115 or PTB Ratio of 1.24. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
Definitive | Deferred Long Term Liab |
Latest Definitive Healthcare's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Definitive Healthcare Corp over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Definitive Healthcare's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Definitive Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 5,403,762 | |
| Geometric Mean | 3,688,915 | |
| Coefficient Of Variation | 99.77 | |
| Mean Deviation | 4,383,682 | |
| Median | 2,116,000 | |
| Standard Deviation | 5,391,090 | |
| Sample Variance | 29.1T | |
| Range | 15.4M | |
| R-Value | 0.77 | |
| Mean Square Error | 12.8T | |
| R-Squared | 0.59 | |
| Significance | 0.0008 | |
| Slope | 927,495 | |
| Total Sum of Squares | 406.9T |
Definitive Deferred Long Term Liab History
About Definitive Healthcare Financial Statements
Investors use fundamental indicators, such as Definitive Healthcare's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 17.5 M | 9.6 M |
Currently Active Assets on Macroaxis
Check out the analysis of Definitive Healthcare Correlation against competitors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 2.187 | Quarterly Revenue Growth (0.04) | Return On Assets (0.01) | Return On Equity (0.55) |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.